E-LIB Suche - Ergebnisse für: Wissinger, E.

1

HTA5 Examining the Impact of Eams on NICE Recommendations o..:

Ringger, D ; Wissinger, E
Value in Health. 27 (2024) 6 - p. S244-S245 , 2024

Link: https://doi.org/10.1016/..

2

CO4 The Burden of Illness of Treatment-Induced Vasomotor Sy..:

Morga, A. ; Shiozawa, A. ; Todorova, L....
Value in Health. 27 (2024) 6 - p. S16 , 2024

Link: https://doi.org/10.1016/..

3

HTA70 Early Patient Access to Life Saving Drugs across Euro..:

Konstanski, M ; Schmidt, K ; Martinez J, Schepis...
Value in Health. 27 (2024) 6 - p. S257 , 2024

Link: https://doi.org/10.1016/..

4

64P Long-term response to regorafenib (REG) in patients wit..:

Peeters, M. ; Pan, X. ; Koufopoulou, M....
Annals of Oncology. 35 (2024) - p. S30-S31 , 2024

Link: https://doi.org/10.1016/..

5

HTA54 AMNOG Benefit Assessment in Germany: Outcomes from 20..:

Wehage, E ; Löpmeier-Röh, J.F. ; Wissinger, E.
Value in Health. 27 (2024) 6 - p. S254 , 2024

Link: https://doi.org/10.1016/..

6

SA39 Exploring the Landscape of Genetically Modified Natura..:

Arregui, M ; Gomez-Espinosa, E ; Cadarette, S.
Value in Health. 27 (2024) 6 - p. S402 , 2024

Link: https://doi.org/10.1016/..

7

PCR239 Quality of Life (QOL) Instruments Used in Clinicaltr..:

Cadarette, S. ; Arregui Rementeria, M. ; Gomez Espinosa, E....
Value in Health. 26 (2023) 12 - p. S495 , 2023

Link: https://doi.org/10.1016/..

8

HTA24 The Use of Real-World Data in Decision Making for Onc..:

Koufopoulou, M. ; Wissinger, E. ; Oladapo, T....
Value in Health. 26 (2023) 6 - p. S262 , 2023

Link: https://doi.org/10.1016/..

9

EE144 Decision Modifiers Under Uncertainty: Comparison of D..:

Poole, C. ; O'Day, K. ; Cadarette, S....
Value in Health. 26 (2023) 12 - p. S78 , 2023

Link: https://doi.org/10.1016/..

10

HTA229 PICO Criteria Applied in Joint Action 3 Differ From ..:

Konstanski, M. ; Gehrman, J. ; Schepis Martinez, J....
Value in Health. 26 (2023) 12 - p. S363-S364 , 2023

Link: https://doi.org/10.1016/..

11

EPH31 Systematic Literature Review on the Global Epidemiolo..:

Arregui Rementeria, M. ; Cadarette, S. ; Oladapo, T....
Value in Health. 26 (2023) 12 - p. S208 , 2023

Link: https://doi.org/10.1016/..

12

HTA41 Surrogate Endpoints in Oncology: A Review of Recent H..:

Wissinger, E. ; Koufopoulou, M. ; Fusco, N....
Value in Health. 26 (2023) 6 - p. S265-S266 , 2023

Link: https://doi.org/10.1016/..

13

HTA33 The Current Impact of ICER Assessments on Payer Decis..:

Faraci, D ; Ha, J ; Ijioma, S..
Value in Health. 25 (2022) 7 - p. S509 , 2022

Link: https://doi.org/10.1016/..

14

P13 Disease-Free Survival as a Potential Surrogate Endpoint..:

Abogunrin, S ; Lorenzi, M ; Cadarette, S...
Value in Health. 25 (2022) 12 - p. S3-S4 , 2022

Link: https://doi.org/10.1016/..

15

PDG79 MULTIVARIATE NETWORK META-ANALYSIS MODELS THAT INCORP..:

Ballew, N. ; Wissinger, E. ; Ruiz, K.
Value in Health. 22 (2019) - p. S176 , 2019

Link: https://doi.org/10.1016/..